Systemic effects of intranasal steroid drops in patients with dysosmia

Journal of Otolaryngology of Japan

Volumn 108, Issue 5, 2005, Pages 528-532

  Makino, Nobuko ^a   Ohta, Yasushi ^a   Ishikawa, Toshio ^a   Ichimura, Keiichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adrenocorticotropic hormone; Bioavailability; Cortisol; Dysosmia; Intranasal steroids

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; STEROID;

ARTICLE; CLINICAL ARTICLE; CORTICOTROPIN BLOOD LEVEL; DYSOSMIA; HUMAN; HYDROCORTISONE BLOOD LEVEL; OLFACTORY DISCRIMINATION; SMELLING DISORDER; SYMPTOMATOLOGY; SYSTEMIC THERAPY; TREATMENT OUTCOME;

EID: 20444362431     PISSN: 00306622     EISSN: None     Source Type: Journal    
DOI: 10.3950/jibiinkoka.108.528     Document Type: Article

References (15)

1. Gazis AG, Homer JJ, Henson DB, Page SR, Jones NS: The effect of six weeks topical nasal betamethasone drops on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis. Clin otolaryngol 1999; 24: 495-498.
2. Stevens DJ: Cushing's syndrome due to the abuse of betamethasone nasal drops. J Laryngol Otol 1988; 102: 219-221.
3. Flynn MD, Beasley P, Tooke JE: Adrenal suppression with intranasal betamethasone drops. J Laryngol Otol 1992; 106: 827-828.
4. Hardy JG, Lee SW, Wilson CG: Intranasal drug delivery by spray and drops. J Pharm Pharmacol Immunol 1985; 37: 294-297.
5. Lipworth BJ, Seckl JR: Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids. Thorax 1997; 52: 476-482.
6. Allen DB: Systemic effects of intranasal steroids: an endocrinologist's perspective. J Allergy Clin Immunol 2000; 106: 179-190.
7. Szefler SJ: Pharmacokinetics of intranasal corticosteroids. J Allergy Clin Immunol 2001; 108: 26-31.